1. Report Overview
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
3. Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1.Drivers
3.2.2.Restraints
3.2.3.Opportunities
3.2.4.Challenges
3.3. PEST-Analysis
3.4. Porter's Diamond Model for France Next Generation Cancer Diagnostics Market
3.5. IGR-Growth Matrix Analysis
3.6. Competitive Landscape in France Next Generation Cancer Diagnostics Market
4. France Next Generation Cancer Diagnostics Market by Technology
4.1. QPCR and Multiplexing
4.2. Benchtop Sequencers
4.3. Lab-on-a-chip
4.4. Next Generation Sequencing
4.5. Protein Microarrays
4.6. DNA Microarrays
4.7. Other
5. France Next Generation Cancer Diagnostics Market by Application
5.1. Biomarker Development
5.2. Proteomic Analysis
5.3. CTC Analysis
5.4. Genetic Analysis
5.5. Epigenetic Analysis
6. France Next Generation Cancer Diagnostics Market by Cancer Type
6.1. Lung Cancer
6.2. Colorectal Cancer
6.3. Breast Cancer
6.4. Prostate Cancer
6.5. Others
7. France Next Generation Cancer Diagnostics Market by Function
7.1. Cancer Screening
7.2. Therapeutic Monitoring
7.3. Prognosis Diagnostics
7.4. Risk Analysis
7.5. Companion Diagnostics
8. Company Profiles
8.1. Company 1
8.2. Company 2
8.3. Company 3
8.4. Company 4
8.5. Company 5
Sales : +91 99239 50043
HR : +91 77578 64143
info@infiniumglobalresearch.com
info@infiniumglobalresearch.net
Privacy Policy
Refund & Cancellation Policy
Terms & Conditions
Careers